Year To Quarter End Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7725247

Concept 2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
45,900,000,000 JPY
46,782,000,000 JPY
Cost of sales
32,630,000,000 JPY
33,532,000,000 JPY
Gross profit (loss)
13,269,000,000 JPY
13,249,000,000 JPY
Selling, general and administrative expenses
Salaries
2,473,000,000 JPY
2,507,000,000 JPY
Depreciation
493,000,000 JPY
381,000,000 JPY
Selling, general and administrative expenses
12,471,000,000 JPY
12,593,000,000 JPY
Operating profit (loss)
798,000,000 JPY
656,000,000 JPY
Non-operating income
Interest income
20,000,000 JPY
20,000,000 JPY
Dividend income
65,000,000 JPY
79,000,000 JPY
Non-operating income
410,000,000 JPY
368,000,000 JPY
Non-operating expenses
Interest expenses
220,000,000 JPY
222,000,000 JPY
Non-operating expenses
376,000,000 JPY
382,000,000 JPY
Ordinary profit (loss)
832,000,000 JPY
642,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
567,000,000 JPY
477,000,000 JPY
Extraordinary income
567,000,000 JPY
477,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
JPY
5,000,000 JPY
Loss on disaster
JPY
36,000,000 JPY
Extraordinary losses
38,000,000 JPY
58,000,000 JPY
Profit (loss) before income taxes
1,361,000,000 JPY
1,061,000,000 JPY
Income taxes - current
386,000,000 JPY
397,000,000 JPY
Income taxes - deferred
5,000,000 JPY
-197,000,000 JPY
Income taxes
391,000,000 JPY
200,000,000 JPY
Profit (loss)
970,000,000 JPY
970,000,000 JPY
970,000,000 JPY
970,000,000 JPY
861,000,000 JPY
861,000,000 JPY
861,000,000 JPY
861,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.